JP2016513523A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513523A5
JP2016513523A5 JP2015562517A JP2015562517A JP2016513523A5 JP 2016513523 A5 JP2016513523 A5 JP 2016513523A5 JP 2015562517 A JP2015562517 A JP 2015562517A JP 2015562517 A JP2015562517 A JP 2015562517A JP 2016513523 A5 JP2016513523 A5 JP 2016513523A5
Authority
JP
Japan
Prior art keywords
solution
item
bile
seq
target area
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015562517A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016513523A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/059765 external-priority patent/WO2014141160A1/en
Publication of JP2016513523A publication Critical patent/JP2016513523A/ja
Publication of JP2016513523A5 publication Critical patent/JP2016513523A5/ja
Pending legal-status Critical Current

Links

JP2015562517A 2013-03-14 2014-03-13 胆汁漏の処置 Pending JP2016513523A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361784496P 2013-03-14 2013-03-14
US61/784,496 2013-03-14
PCT/IB2014/059765 WO2014141160A1 (en) 2013-03-14 2014-03-13 Treatment for bile leakage

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018079164A Division JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Publications (2)

Publication Number Publication Date
JP2016513523A JP2016513523A (ja) 2016-05-16
JP2016513523A5 true JP2016513523A5 (enExample) 2017-04-13

Family

ID=50397217

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015562517A Pending JP2016513523A (ja) 2013-03-14 2014-03-13 胆汁漏の処置
JP2018079164A Pending JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018079164A Pending JP2018130552A (ja) 2013-03-14 2018-04-17 胆汁漏の処置

Country Status (5)

Country Link
US (1) US20160030628A1 (enExample)
EP (1) EP2968654A1 (enExample)
JP (2) JP2016513523A (enExample)
HK (1) HK1220145A1 (enExample)
WO (1) WO2014141160A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105435211A (zh) 2008-10-06 2016-03-30 三维肽胶株式会社 组织闭塞剂
EP2869903B1 (en) 2012-07-06 2018-11-28 3-D Matrix Ltd. Fill-finish process for peptide solutions
US20160287744A1 (en) 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
DK3116896T3 (en) 2014-03-10 2019-03-18 3 D Matrix Ltd SELF-PREPARING PEPTIME COMPOSITIONS
ES3037364T3 (en) 2014-03-10 2025-10-01 3 D Matrix Ltd Sterilization and filtration of peptide compositions
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
US20190091376A1 (en) * 2016-03-18 2019-03-28 3-D Matrix, Ltd. Preventing Biological Tissue Adhesion
CN109195640A (zh) * 2016-03-18 2019-01-11 立美基股份有限公司 脑脊液漏堵塞
JP2019508175A (ja) * 2016-03-18 2019-03-28 株式会社スリー・ディー・マトリックス 膵液瘻の閉鎖
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2572964C (en) * 2004-07-06 2018-03-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
KR20100102750A (ko) * 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
CN105435211A (zh) * 2008-10-06 2016-03-30 三维肽胶株式会社 组织闭塞剂
US8962784B2 (en) * 2008-12-19 2015-02-24 Ethicon, Inc. Isocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant

Similar Documents

Publication Publication Date Title
JP2016515113A5 (enExample)
Tyler et al. Nanomedicine for treating spinal cord injury
ES2898655T3 (es) Métodos de reparación y regeneración de tejidos
JP2017513927A5 (enExample)
JP2017519568A5 (enExample)
JP2017513928A5 (enExample)
CA2703234C (en) An inhalable dry powder formulation comprising glp-1 for use by pulmonary inhalation
JP2018130552A (ja) 胆汁漏の処置
JP2016501066A5 (enExample)
JP2016539921A5 (enExample)
JP2017513927A (ja) 肺の漏出を治療するための自発組織化ペプチド
EP4309722A3 (en) Ingestible device for delivery of therapeutic agent to the gastrointestinal tract
RU2016127558A (ru) Стероидное соединение для применения в лечении печеночной энцефалопатии
JP2019508175A (ja) 膵液瘻の閉鎖
JP2016535044A (ja) 次亜塩素酸ナトリウムを含む抗炎症溶液
RU2015148636A (ru) Модуляция активности гепарин-связывающего эпидермального фактора роста для заживления барабанной перепонки
JP2019518569A5 (enExample)
RU2018100879A (ru) Быстродействующая распадающаяся в ротовой полости пленка для проведения местного обезболивания
JP2019518569A (ja) 内視鏡的剥離術後の食道狭窄を予防するための自己集合性ペプチドマトリックス
KR102200656B1 (ko) 마이크로스피어를 포함하는 개선된 창상 치료 조성물
ME02644B (me) Novi preparati alfentanila za tretman akutnog bola
US20170258716A1 (en) Anti-cancer agent for use in combination therapy of high intensity focused ultrasound therapy and anti-cancer agent therapy
EP4192492A2 (en) Topical and parenteral use and administration of self-assembling amphiphilic peptide hydrogels
WO2021022112A1 (en) Alginate-based microcapsulation for the delivery of alpha-cgrp in cardiovascular diseases
WO2016205459A3 (en) Therapeutic nanofiber hydrogels for local treatment of brain-related diseases